Seoul: Hanall Biopharma Co. on Wednesday reported its second-quarter net profit of 599 million won (US$433,210), swinging from a loss of 3.3 billion won a year earlier.

According to Yonhap News Agency, the company achieved an operating profit for the April-June period of 1.1 billion won, compared to a loss of 3.1 billion won in the same period last year. Additionally, the company's sales increased by 28.8 percent, reaching 40.7 billion won.